OncoDaily
banner
oncodaily.bsky.social
OncoDaily
@oncodaily.bsky.social
Your daily dose of hope, inspiration, and information in the fight against cancer.
oncodaily.com
Bristol Myers Squibb Announces Collaboration with Microsoft to Accelerate the Early Detection of Lung Cancer - Nathan Pennell

@n8pennell.bsky.social

oncodaily.com/voices/brist...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
January 21, 2026 at 9:52 PM
Potential Anti-Cancer Fungal Compound Verticillin A Finally Synthesized After More Than 50 Years

oncodaily.com/science/vert...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Verticillin
January 12, 2026 at 8:59 PM
The Scientist’s Energy Audit: Free Framework For Scientists - Oliver Bogler

@oliverbogler.bsky.social

oncodaily.com/voices/olive...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
December 21, 2025 at 9:21 PM
December 20, 2025 at 8:00 PM
Historic move in Santo Domingo! PAHO Director Dr. Barbosa and Dominican Senate President Ricardo de los Santos signed a landmark Technical Cooperation Agreement. Legislative action is key to universal health.

oncodaily.com/public-healt...

#PAHO #DominicanRepublic #HealthLegislation #PHC #OPS
December 3, 2025 at 5:15 PM
November 28, 2025 at 10:52 PM
November 24, 2025 at 12:06 AM
November 17, 2025 at 11:00 PM
FGD3 as a Critical Modulator of Chemotherapy and Immunotherapy Response in Breast Cancer

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 16, 2025 at 6:20 PM
UICC World Cancer Leaders’ Summit 2025: Bridging Divides, Building Futures

@uiccofficial.bsky.social

oncodaily.com/voices/uicc-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 16, 2025 at 6:19 PM
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Daratumumab #MM #Myeloma
November 9, 2025 at 9:10 PM
SWOG S1605: UroAmp utDNA Predicts Immunotherapy Response in Bladder Cancer

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 7, 2025 at 9:46 PM
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

oncodaily.com/community/10...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 7, 2025 at 9:45 PM
November 4, 2025 at 8:37 PM
Evolution Trial Evaluates Radiotherapy-Free Chemoimmunotherapy with Pembrolizumab in Locally Advanced NSCLC with High PD-L1 Expression

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Evolution #Chemoimmunotherapy #Pembrolizumab #NSCLC
November 3, 2025 at 1:49 PM
LEAP-012: Pembrolizumab Plus Lenvatinib with Transarterial Chemoembolization in Unresectable, Non-Metastatic HCC

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LEAP-012 #HCC
November 2, 2025 at 9:41 PM
Immunotherapy Improves Survival in MSI-H Colon Cancer with Isolated Peritoneal Metastases

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ColonCancer
November 2, 2025 at 9:38 PM
LITESPARK-011: Dual HIF-2α and VEGF Pathway Blockade Demonstrates Superiority Over Cabozantinib Following PD-1/L1 Therapy in Advanced Renal Cell Carcinoma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #RCC #RenalCellCarcinoma #LITESPARK-011
October 31, 2025 at 1:36 PM
Predictive Modeling for Immunotherapy Response in Cancer: From Biomarkers to AI Integration

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Immunotherapy #IO
October 29, 2025 at 9:37 PM
Gevorg Tamamyan Recognized as Fellow of the American Society of Clinical Oncology (FASCO)

@ascocancer.bsky.social

oncodaily.com/voices/gevor...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ASCO #FASCO
October 29, 2025 at 9:36 PM
mRNA COVID-19 Vaccines Reprogram Tumor Immunity and Enhance Response to Checkpoint Inhibitors

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #COVID-19 #mRNAVaccine
October 28, 2025 at 8:49 PM
FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #FDA #Melanoma
October 26, 2025 at 9:14 PM
FDA Grants Breakthrough Therapy Designation to Zenocutuzumab-zbco for NRG1-Positive Cholangiocarcinoma

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Cholangiocarcinoma
October 24, 2025 at 8:50 PM
Dual Immune Checkpoint Blockade Targeting TIGIT and PD-1 Improves Outcomes in Advanced Gastroesophageal Adenocarcinoma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GastroesophagealAdenocarcinoma #GIOnc
October 15, 2025 at 12:11 AM
PIVOTAL Trial Shows Daromun Improves Recurrence-Free Survival in Stage III Melanoma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Melanoma #PIVOTAL
October 9, 2025 at 7:08 AM